Suppr超能文献

β受体阻滞剂对受过训练和未受过训练男性运动能力的影响:血流动力学比较

Effects of beta-blockade on exercise capacity of trained and untrained men: a hemodynamic comparison.

作者信息

Joyner M J, Freund B J, Jilka S M, Hetrick G A, Martinez E, Ewy G A, Wilmore J H

出版信息

J Appl Physiol (1985). 1986 Apr;60(4):1429-34. doi: 10.1152/jappl.1986.60.4.1429.

Abstract

To study the effects of cardiovascular fitness on hemodynamic responses to exercise during beta-adrenergic blockade (BAB), submaximal [60% of maximum O2 uptake (VO2max)] and maximal treadmill exercise data were collected in 11 trained (T, VO2max 63.3 ml X kg-1 X min-1, 26.8 yr) and 11 untrained (UT, VO2max 44.5 ml X kg-1 X min-1, 25.0 yr) male subjects. Subjects completed two maximal control tests followed by a randomized, double-blind series of maximal tests after 1-wk treatments with placebo (PLAC), propranolol (PROP, 160 mg/day, beta 1- and beta 2-blockade), and atenolol (ATEN, 100 mg/day, beta 1-blockade). Treatments were separated by 1-wk washout periods. At 60% of control VO2max T and UT subjects experienced no reductions in O2 uptake (VO2) with either drug. Submaximal heart rate (HR, beats/min) was 134.8 PLAC, 107.0 PROP, 107.9 ATEN (P less than 0.05 both drugs vs. PLAC) in T subjects and 141.1 PLAC, 106.1 PROP, and 105.0 ATEN (P less than 0.05 both drugs vs. PLAC) in UT subjects. Cardiac output (1/min) for T was 17.3 PLAC, 16.9 PROP, 16.5 ATEN (P less than 0.05 ATEN vs. PLAC in T only) and for UT it was 12.2 (PLAC), 11.7 (PROP), 11.5 (ATEN) (P less than 0.05 both drugs vs. PLAC in UT). Stroke volume increased from 129.8 ml (PLAC) to 158.6 (PROP) and 156.2 (ATEN) in T (P less than 0.05 both drugs vs. PLAC) and from 86.8 (PLAC) to 110.0 (PROP) and 109.8 (ATEN) (P less than 0.05 both drugs vs. PLAC) in UT. The increases in stroke volume (SV) were similar in both groups.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

为研究心血管适应性对β-肾上腺素能阻滞剂(BAB)期间运动血流动力学反应的影响,我们收集了11名训练有素的男性受试者(T组,最大摄氧量[VO2max]为63.3 ml·kg-1·min-1,26.8岁)和11名未经训练的男性受试者(UT组,VO2max为44.5 ml·kg-1·min-1,25.0岁)次极量[最大摄氧量(VO2max)的60%]和极量跑步机运动数据。受试者先完成两次极量对照测试,然后在接受安慰剂(PLAC)、普萘洛尔(PROP,160 mg/天,β1和β2受体阻滞剂)和阿替洛尔(ATEN,100 mg/天,β1受体阻滞剂)1周治疗后,进行随机、双盲的极量测试系列。治疗之间间隔1周的洗脱期。在对照VO2max的60%时,T组和UT组受试者使用任何一种药物时摄氧量(VO2)均未降低。T组受试者次极量心率(HR,次/分钟)在PLAC时为134.8,PROP时为107.0,ATEN时为107.9(两种药物与PLAC相比P均<0.05);UT组受试者在PLAC时为141.1,PROP时为106.1,ATEN时为105.0(两种药物与PLAC相比P均<0.05)。T组心输出量(L/分钟)在PLAC时为17.3,PROP时为16.9,ATEN时为16.5(仅T组中ATEN与PLAC相比P<0.05);UT组心输出量在PLAC时为12.2,PROP时为11.7,ATEN时为11.5(UT组中两种药物与PLAC相比P均<0.05)。T组每搏输出量从129.8 ml(PLAC)增加到158.6(PROP)和156.2(ATEN)(两种药物与PLAC相比P均<0.05);UT组每搏输出量从86.8(PLAC)增加到110.0(PROP)和109.8(ATEN)(两种药物与PLAC相比P均<0.05)。两组每搏输出量(SV)的增加相似。(摘要截断于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验